| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |